QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · IEX Real-Time Price · USD
97.11
-0.07 (-0.07%)
At close: Jul 1, 2022 4:00 PM
99.00
+1.89 (1.95%)
After-hours: Jul 1, 2022 7:56 PM EDT
-0.07%
Market Cap 6.50B
Revenue (ttm) 2.33B
Net Income (ttm) 1.01B
Shares Out 66.93M
EPS (ttm) 22.98
PE Ratio 4.23
Forward PE 20.33
Dividend n/a
Ex-Dividend Date n/a
Volume 469,344
Open 97.14
Previous Close 97.18
Day's Range 95.02 - 97.71
52-Week Range 88.05 - 180.06
Beta 0.03
Analysts Buy
Price Target 163.20 (+68.1%)
Earnings Date Aug 4, 2022

About QDEL

QuidelOrtho Corporation provides various in vitro diagnostics products worldwide. The company's product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and clinical and at-home products to detect COVID-19. It provides visually-read lateral flow products in infectious disease and reproductive health; direct fluorescent antibodies in infectious disease and virology; micro-titer production with a focus on bone and complement pathway markets; fluorescent immunoassay product... [Read more...]

Industry Health Care Equipment & Supplies
Founded 1979
CEO Douglas Bryant
Employees 1,600
Stock Exchange NASDAQ
Ticker Symbol QDEL
Full Company Profile

Financial Performance

In 2021, QuidelOrtho's revenue was $1.70 billion, an increase of 2.22% compared to the previous year's $1.66 billion. Earnings were $704.23 million, a decrease of -13.09%.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is 163.2, which is an increase of 68.06% from the latest price.

Price Target
$163.2
(68.06% upside)
Analyst Consensus: Buy
Stock Forecasts

News

5 Stocks With Robust Sales Growth to Beat Recession Woes

Steady sales growth is the key to survival for a business, even during recessions. Let's check at Boyd Gaming (BYD), Lithia Motors (LAD), Everest Re (RE), Jones Lang LaSalle (JLL) & QuidelOrtho (QDEL) t...

Other symbols: BYDJLLLADRE

Is the Options Market Predicting a Spike in QuidelOrtho (QDEL) Stock?

Investors need to pay close attention to QuidelOrtho (QDEL) stock based on the movements in the options market lately.

Is QuidelOrtho (QDEL) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease...

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) — QuidelOrtho announces that its subsidiary, Quidel Corporation, is collaborating with the American Heart Association, ...

QuidelOrtho (QDEL) Stock Jumps 3.9%: Will It Continue to Soar?

QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Quidel Corp.—Developer of Only FDA-Cleared FIA Rapid Point-of-Care Diagnostic Lyme Disease Test—To Partner With Renow...

SAN DIEGO--(BUSINESS WIRE)-- #LymeDisease--With Lyme disease season in full-swing across the United States and as the public continues spending increasing time outdoors during the COVID-19 pandemic, Qui...

Quidel (QDEL) Down 9.8% Since Last Earnings Report: Can It Rebound?

Quidel (QDEL) reported earnings 30 days ago. What's next for the stock?

Here's Why You Should Retain QuidelOrtho (QDEL) Stock For Now

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings...

Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (Nasdaq: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced tod...

Quidel (QDEL) Q1 Earnings, Revenues Surpass Estimates, Up Y/Y

Quidel's (QDEL) robust performance across two of its product categories drives its first-quarter 2022 top line.

Quidel (QDEL) Q1 Earnings and Revenues Top Estimates

Quidel (QDEL) delivered earnings and revenue surprises of 25.65% and 21.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Quidel Reports First Quarter 2022 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financia...

Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?

Quidel's (QDEL) first-quarter results are likely to reflect continued strength across its SARS-related products.

Quidel to Hold Fiscal First Quarter 2022 Financial Results Conference Call on May 4th, 2022

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fisc...

Quidel Corporation (QDEL) Reports Solid Preliminary Q1 Revenues

Quidel's (QDEL) revenue growth in the first quarter is likely to have been boosted by continued robust sales of its SARS-related products.

Quidel Announces Preliminary Revenue for First Quarter 2022

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced tod...

Quidel (QDEL) Crossed Above the 50-Day Moving Average: What That Means for Investors

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?

Quidel (QDEL) Just Reclaimed the 20-Day Moving Average

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Wall Street Analysts Think Quidel (QDEL) Could Surge 52%: Read This Before Placing a Bet

The consensus price target hints at a 52.1% upside potential for Quidel (QDEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate rev...

ORTHO CLINICAL INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Orth...

CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Ortho Clinical Diagnostics Holdings plc (NasdaqGS: OCDX) to Quidel Corporation (NasdaqGS: QDEL). Under the term...

Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now

Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat

Quidel (QDEL) stock rallies on better-than-expected fourth-quarter performance and strong diagnostics portfolio.

Quidel to Present at Raymond James 43rd Annual Institutional Investors Conference

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today ...

Wall Street Analysts Believe Quidel (QDEL) Could Rally 47%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 46.8% in Quidel (QDEL). While the effectiveness of this highly sought-after metric is questionable, the positive ...